Application Nr Approved Date Route Status External Links
NDA011366 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Keveyis™ Is Indicated For The Treatment Of Primary Hyperkalemic Periodic Paralysis, Primary Hypokalemic Periodic Paralysis, And Related Variants. Keveyis™ Is An Oral Carbonic Anhydrase Inhibitor Indicated For The Treatment Of Primary Hyperkalemic Periodic Paralysis, Primary Hypokalemic Periodic Paralysis, And Related Variants ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dichlorphenamide DICHLORPHENAMIDE ZINC896918

Comments